We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




US Administration Plans on Mapping the Human Brain

By LabMedica International staff writers
Posted on 11 Mar 2013
The Obama administration is planning a major scientific initiative, the mapping the human brain, to understand how it functions and malfunctions.

The initiative, dubbed the Brain Activity Map (BAM), will seek to map each of the approximately 100 billion neurons in the human brain, although initial studies will be performed in mice and other animals. More...
The proposal for the project will be delivered to the US Congress as part of the president's budget package, and will carry a price tag of roughly USD 300 million a year over 10 years, totaling USD 3 billion. The effort is designed to be a collaboration between several federal agencies, including the National Institutes of Health (NIH; Bethesda, MD, USA), the National Science Foundation (NSF; Arlington, VA, USA), and private organizations.

News reports about the initiative indicated that a 2012 scientific commentary outlined experimental plans for the project, including a variety of specific experimental techniques that might be used to achieve what is termed as the functional connectome, as well as new technologies that will have to be developed in the course of the project. Initial studies might be done in Caenorhabditis elegans, followed by Drosophila, because of their comparatively simple neural circuits. Mid-term studies could be done in zebrafish, mice, and the Etruscan shrew, with studies ultimately to be done in primates and humans.

The project involves the development of nanoparticles that could be used as voltage sensors that would detect individual action potentials, as well as nanoprobes serving as electrophysiological multielectrode arrays. Other methods could use wireless, noninvasive methods of neuronal activity detection such as microelectronic very-large-scale integration and synthetic biology, rather than microelectronics. A related technique proposed the use of high-throughput DNA sequencing for rapidly mapping neural connectivity. The data would be analyzed and modeled by large scale computation. A description of the BAM project and the challenges it faces was published on February 22, 2013, in Neuron.

“To succeed, the BAM Project needs two critical components: strong leadership from funding agencies and scientific administrators, and the recruitment of a large coalition of interdisciplinary scientists,” concluded report coauthor Paul Alivisato, PhD, director of the Lawrence Berkeley National Laboratory (Berkeley, CA, USA), and colleagues. “We believe that neuroscience is ready for a large-scale functional mapping of the entire brain circuitry, and that such mapping will directly address the emergent level of function, shining much-needed light into the ‘impenetrable jungles’ of the brain.”

Related Links:

National Institutes of Health
National Science Foundation
Lawrence Berkeley National Laboratory



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.